DocMorris AG (ZRSEF)
90.00
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
DocMorris Debt to Equity Ratio: 0.7017 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7017 |
| June 30, 2023 | 0.7538 |
| December 31, 2022 | 1.398 |
| June 30, 2022 | 1.218 |
| December 31, 2021 | 1.001 |
| June 30, 2021 | 1.040 |
| December 31, 2020 | 0.9101 |
| June 30, 2020 | 1.344 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.7699 |
| June 30, 2019 | 0.3956 |
| December 31, 2018 | 0.2581 |
| June 30, 2018 | 0.0388 |
| December 31, 2017 | 0.0015 |
| June 30, 2017 | 0.6113 |
| December 31, 2016 | 0.5295 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3956
Minimum
Jun 2019
1.398
Maximum
Dec 2022
0.9533
Average
0.9555
Median
Debt to Equity Ratio Benchmarks
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | 0.00 |
| Addex Therapeutics Ltd | 0.00 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.032B |
| Total Liabilities (Quarterly) | 518.95M |
| Shareholders Equity (Quarterly) | 512.57M |
| Current Ratio | 1.629 |
| Net Debt Paydown Yield | 5.60% |